The scale of the GLP-1 market is well understood by anyone working in pharmaceutical manufacturing. Semaglutide and tirzepatide, at least in the context of weight lo...

One of the greatest barriers to circularity in healthcare plastics has not been collection or recycling alone, but proof. In regulated healthcare applications, it is...

Why usability, safety and evolving regulation are reshaping preservativefree eye care In ophthalmic therapy, the package is no longer a passive container. It has...

These days, a patient searching online for weight management treatment might come across two websites that look equally legitimate. One may belong to a regulated pha...

Pharmaceutical development generates huge amounts of analytical data and metadata, but volume is not the core problem. The real challenge is data fragmentation. The ...

Though pharmaceutical organisations have more sustainability data than ever before, the value of this data often remains limited to one-off reporting exercises, rath...